Diasorin reported EUR245.56M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Amplifon EUR 534.52M 8.4M Sep/2026
Brookdale Senior Living USD -28.98M 26.96M Jun/2026
Cencora USD 83.54B 6.54B Jun/2026
Diasorin EUR 245.56M 14.56M Jun/2026
Encompass Health USD 1.32B 1.28B Sep/2026
Enovis USD 560.51M 19.4M Jun/2026
GE HealthCare Technologies USD 4.71B 93M Sep/2026
OPKO Health USD 188.62M 13.41M Jun/2026
Pediatrix Medical Group USD 439.1M 20.23M Dec/2025
Veradigm USD 188M 61.08M Dec/2022
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026